Greenbrook TMS 과거 수익 실적

과거 기준 확인 0/6

Greenbrook TMS의 수입은 연평균 -33%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 5.4%의 비율로 증가했습니다. 매출은 연평균 18.4%의 비율로 증가해 왔습니다.

주요 정보

-33.0%

수익 성장률

-6.6%

EPS 성장률

Healthcare 산업 성장	8.5%
매출 성장률	18.4%
자기자본 수익률	n/a
순이익	-69.4%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Market Still Lacking Some Conviction On Greenbrook TMS Inc. (NASDAQ:GBNH)

Nov 01

수익 및 비용 분석

Greenbrook TMS 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

OTCPK:GBNH.F 수익, 비용 및 수입 (USD Millions )
날짜	수익	수익	G+A 비용
30 Jun 24	75	-52	32
31 Mar 24	72	-53	32
31 Dec 23	74	-49	31
30 Sep 23	74	-92	30
30 Jun 23	77	-96	37
31 Mar 23	73	-90	36
31 Dec 22	67	-88	36
30 Sep 22	62	-38	35
30 Jun 22	54	-26	28
31 Mar 22	54	-25	27
31 Dec 21	52	-25	27
30 Sep 21	48	-26	27
30 Jun 21	47	-30	26
31 Mar 21	43	-33	24
31 Dec 20	43	-30	22
30 Sep 20	46	-28	21
30 Jun 20	42	-24	20
31 Mar 20	40	-17	20
31 Dec 19	36	-16	21
30 Sep 19	30	-10	16
30 Jun 19	27	-8	13
31 Mar 19	24	-6	11
31 Dec 18	21	-5	9
30 Sep 18	18	-5	7
30 Jun 18	16	-4	7
31 Mar 18	15	-3	5
31 Dec 17	14	-2	5
31 Dec 16	7	-2	3
31 Dec 15	4	-2	2

양질의 수익: GBNH.F 은(는) 현재 수익성이 없습니다.

이익 마진 증가: GBNH.F 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: GBNH.F 은(는) 수익성이 없으며 지난 5년 동안 연간 33% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 GBNH.F 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: GBNH.F 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare 업계( 10.3% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: GBNH.F 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

Greenbrook TMS 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Third quarter 2023 earnings released: US$0.30 loss per share (vs US$0.59 loss in 3Q 2022)

Greenbrook TMS Inc. to Report Q3, 2023 Results on Nov 08, 2023

Second quarter 2023 earnings released: US$0.30 loss per share (vs US$0.41 loss in 2Q 2022)

Greenbrook TMS Inc. to Report Q2, 2023 Results on Aug 15, 2023

Greenbrook TMS Inc. to Report Q1, 2023 Results on May 15, 2023

Full year 2022 earnings released: US$2.66 loss per share (vs US$1.61 loss in FY 2021)

Recent updates

Greenbrook TMS Inc. announced delayed 10-Q filing

Neuronetics Intends to Cause the Common Shares of Greenbrook to Be Delisted from the OTCQB

Greenbrook TMS Inc. Announces Passing of Board Member Elias Vamvakas

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Madryn Asset Management Engages with Greenbrook TMS Inc.

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Greenbrook TMS Inc., Annual General Meeting, Jun 26, 2024

Greenbrook TMS Inc., Annual General Meeting, Jun 26, 2024

Madryn Asset Management Engages in Discussions with Greenbrook TMS

Greenbrook TMS Inc. announced delayed annual 10-K filing

Greenbrook TMS Intends to File Form 25 to Delist Common Shares

Greenbrook TMS Inc. Appoints Andrew Crish as Chief Operating Officer

Greenbrook TMS Inc. has completed a Follow-on Equity Offering in the amount of $0.56565 million.

Greenbrook TMS Inc. has filed a Follow-on Equity Offering in the amount of CAD 1.2 million.

Greenbrook TMS Inc. has filed a Follow-on Equity Offering in the amount of CAD 1.2 million.

Greenbrook TMS Inc. has filed a Follow-on Equity Offering in the amount of CAD 1.2 million.

Greenbrook TMS Inc. announced that it has received $2.538071 million in funding

New major risk - Market cap size

Greenbrook TMS Inc. announced that it has received $1.522843 million in funding

Greenbrook TMS Inc. Appoints Peter Willett as Chief Financial Officer

Greenbrook TMS Inc. Appoints Juliana Elstad as an Independent Director and Member of Governance and Nominating Committee

Greenbrook TMS Inc. announced that it has received $5.262952 million in funding

Greenbrook TMS Inc. announced that it expects to receive $4.015548 million in funding from Madryn Asset Management, LP

New major risk - Share price stability

New major risk - Market cap size

Greenbrook TMS Inc. Announces Settlement of Ongoing Litigation

Greenbrook TMS Receives Nasdaq Delisting Notice and Intends to Appeal

Price target decreased by 44% to US$1.00

Third quarter 2023 earnings released: US$0.30 loss per share (vs US$0.59 loss in 3Q 2022)

Greenbrook TMS Inc. Announces Board and Committee Changes

Market Still Lacking Some Conviction On Greenbrook TMS Inc. (NASDAQ:GBNH)

Greenbrook TMS Inc. to Report Q3, 2023 Results on Nov 08, 2023

New major risk - Market cap size

Greenbrook Announces Chief Financial Officer Changes

New major risk - Shareholder dilution

Greenbrook TMS Inc. announced that it has received $2 million in funding from Greybrook Health Inc.

Second quarter 2023 earnings released: US$0.30 loss per share (vs US$0.41 loss in 2Q 2022)

Greenbrook TMS Inc. to Report Q2, 2023 Results on Aug 15, 2023

Greenbrook TMS Inc. announced that it expects to receive CAD 4.458156 million in funding from Alumni Capital LP

Insufficient new directors

Greenbrook TMS Inc. Announces Board Changes

Check Five LLC Files a Complaint Against Greenbrook TMS Inc. and TMS NeuroHealth Centers, Inc

Greenbrook TMS Receives Notification from Nasdaq Regarding Minimum Bid Price Requirement

Greenbrook TMS Inc. to Report Q1, 2023 Results on May 15, 2023

Insufficient new directors

Full year 2022 earnings released: US$2.66 loss per share (vs US$1.61 loss in FY 2021)

Greenbrook TMS Inc. announced that it has received $0.75 million in funding

Insufficient new directors

Third quarter 2022 earnings released: US$0.59 loss per share (vs US$0.22 loss in 3Q 2021)

Greenbrook TMS Inc. to Report Q3, 2022 Results on Nov 08, 2022

Second quarter 2022 earnings released: US$0.41 loss per share (vs US$0.48 loss in 2Q 2021)

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기